Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients.
Durastanti V, Lugaresi A, Bramanti P, Amato M, Bellantonio P, De Luca G, Picconi O, Fantozzi R, Locatelli L, Solda' A, Sessa E, Totaro R, Marino S, Zipoli V, Zorzon M, Millefiorini E. Durastanti V, et al. Among authors: zorzon m. J Transl Med. 2011 Apr 18;9:42. doi: 10.1186/1479-5876-9-42. J Transl Med. 2011. PMID: 21501517 Free PMC article. Clinical Trial.
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study.
Bastianello S, Giugni E, Amato MP, Tola MR, Trojano M, Galletti S, Luccichenti G, Quarantelli M, Picconi O, Patti F; COGIMUS study group. Bastianello S, et al. BMC Neurol. 2011 Oct 14;11:125. doi: 10.1186/1471-2377-11-125. BMC Neurol. 2011. PMID: 21999142 Free PMC article. Clinical Trial.
Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
Zivadinov R, Locatelli L, Cookfair D, Srinivasaraghavan B, Bertolotto A, Ukmar M, Bratina A, Maggiore C, Bosco A, Grop A, Catalan M, Zorzon M. Zivadinov R, et al. Among authors: zorzon m. Mult Scler. 2007 May;13(4):490-501. doi: 10.1177/1352458506070446. Epub 2007 Feb 9. Mult Scler. 2007. PMID: 17463072 Clinical Trial.
Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
Zivadinov R, Bagnato F, Nasuelli D, Bastianello S, Bratina A, Locatelli L, Watts K, Finamore L, Grop A, Dwyer M, Catalan M, Clemenzi A, Millefiorini E, Bakshi R, Zorzon M. Zivadinov R, et al. Among authors: zorzon m. J Neurol Sci. 2004 Aug 30;223(2):185-93. doi: 10.1016/j.jns.2004.05.010. J Neurol Sci. 2004. PMID: 15337621
MMP-9 microsatellite polymorphism and multiple sclerosis.
Fiotti N, Zivadinov R, Altamura N, Nasuelli D, Bratina A, Tommasi MA, Bosco A, Locatelli L, Grop A, Cazzato G, Guarnieri G, Giansante C, Zorzon M. Fiotti N, et al. Among authors: zorzon m. J Neuroimmunol. 2004 Jul;152(1-2):147-53. doi: 10.1016/j.jneuroim.2004.03.009. J Neuroimmunol. 2004. PMID: 15223247
93 results